The Valley Desk

NCT04516967 · Interventional trial

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Overall registry status Completed

Phase 3

Conditions Immune Thrombocytopenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov